Chemoinformaics analysis of Dehydrosabinaketone
| Molecular Weight | 136.194 | nRot | 1 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 20 |
| Exact Molecular Weight | 136.089 | nRing | 2 |
| Solubility: LogS | -7.163 | nHRing | 0 |
| Solubility: LogP | 7.452 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 23.8335 |
| nHD | 0 | BPOL | 12.9065 |
| QED | 0.436 |
| Synth | 4.551 |
| Natural Product Likeliness | 2.729 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.035 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.7 |
| MDCK | 0.00000829 |
| BBB | 0.933 |
| PPB | 0.988963 |
| VDSS | 1.477 |
| FU | 0.0101574 |
| CYP1A2-inh | 0.051 |
| CYP1A2-sub | 0.523 |
| CYP2c19-inh | 0.08 |
| CYP2c19-sub | 0.936 |
| CYP2c9-inh | 0.115 |
| CYP2c9-sub | 0.244 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.501 |
| CYP3a4-inh | 0.274 |
| CYP3a4-sub | 0.645 |
| CL | 17.218 |
| T12 | 0.01 |
| hERG | 0.014 |
| Ames | 0.015 |
| ROA | 0.031 |
| SkinSen | 0.044 |
| Carcinogencity | 0.026 |
| EI | 0.015 |
| Respiratory | 0.66 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.927791 |